BeGraft Coronary Stent Graft System - Mesh-sleeve coronary artery stent

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Device Technologies Australia Pty Ltd

Classe:

Class III

Prodotto da:

Bentley InnoMed GmbH Lotzenacker 3, Hechingen, 72379 Germany

Area terapeutica:

57788 - Mesh-sleeve coronary artery stent

Indicazioni terapeutiche:

The BeGraft Coronary Stent Graft System consists of: - a balloon-expandable cobalt-chromium (L605) stent, covered with an ePTFE graft material, which is - pre-mounted on the balloon of a rapid exchange (RX)stent delivery system. The delivery system is compatible with 0.014? guide wires and is available in usable lengths of 143 cm and 153 cm. The BeGraft Coronary Stent Graft System is indicated for transluminal implantation in coronary arteries or aorto-coronary bypass grafts for the treatment of: 1. Acute perforation or rupture of coronary arteries. 2. Aneurysm of coronary arteries or coronary bypass-vein graft.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2016-08-03